Kathryn D Fischer1, Alex C W Houston1,2, Rajeev I Desai3, Michelle R Doyle3, Jack Bergman3, Maha Mian1, Rebekah Mannix4, David L Sulzer5, Se Joon Choi5, Eugene V Mosharov5, Nathaniel W Hodgson1, Anita Bechtholt6, Klaus A Miczek7, Paul A Rosenberg8,9. 1. Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. 2. Department of Brain and Cognitive Sciences, Massachusetts Institute of Technology, Cambridge, MA, 02139, USA. 3. Preclinical Pharmacology Program, McLean Hospital/Harvard Medical School, Belmont, MA, 02478, USA. 4. Division of Emergency Medicine, Boston Children's Hospital, Boston, MA, 02115, USA. 5. Department of Neurology, Columbia University, New York, NY, 10032, USA. 6. National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, 20892, USA. 7. Departments of Psychiatry, Pharmacology, and Neuroscience, Tufts University, Boston, MA, 02111, USA. 8. Department of Neurology and the F.M. Kirby Neurobiology Center, Boston Children's Hospital, Boston, MA, 02115, USA. paul.rosenberg@childrens.harvard.edu. 9. Program in Neuroscience, Harvard Medical School, Boston, MA, 02115, USA. paul.rosenberg@childrens.harvard.edu.
Abstract
RATIONALE: GLT-1 is the major glutamate transporter in the brain and is expressed predominantly in astrocytes but is also present in excitatory axon terminals. To understand the functional significance of GLT-1 expressed in neurons, we generated a conditional GLT-1 knockout mouse and inactivated GLT-1 in neurons using Cre-recombinase expressed under the synapsin 1 promoter, (synGLT-1 KO). OBJECTIVES: Abnormalities of glutamate homeostasis have been shown to affect hippocampal-related behaviors including learning and memory as well as responses to drugs of abuse. Here, we asked whether deletion of GLT-1 specifically from neurons would affect behaviors that assessed locomotor activity, cognitive function, sensorimotor gating, social interaction, as well as amphetamine-stimulated locomotor activity. METHODS/ RESULTS: We found that the neuronal GLT-1 KO mice performed similarly to littermate controls in the behavioral tests we studied. Although performance in open field testing was normal, the acute locomotor response to amphetamine was significantly blunted in the synGLT-1 KO (40% of control). We found no change in amphetamine-stimulated extracellular dopamine in the medial shell of the nucleus accumbens, no change in electrically stimulated or amphetamine-induced dopamine release, and no change in dopamine tissue content. CONCLUSIONS: These results support the view that GLT-1 expression in neurons is required for amphetamine-induced behavioral activation, and suggest that this phenotype is not produced through a change in dopamine uptake or release. Although GLT-1 is highly expressed in neurons in the CA3 region of the hippocampus, the tests used in this study were not able to detect a behavioral phenotype referable to hippocampal dysfunction.
RATIONALE: GLT-1 is the major glutamate transporter in the brain and is expressed predominantly in astrocytes but is also present in excitatory axon terminals. To understand the functional significance of GLT-1 expressed in neurons, we generated a conditional GLT-1 knockout mouse and inactivated GLT-1 in neurons using Cre-recombinase expressed under the synapsin 1 promoter, (synGLT-1 KO). OBJECTIVES: Abnormalities of glutamate homeostasis have been shown to affect hippocampal-related behaviors including learning and memory as well as responses to drugs of abuse. Here, we asked whether deletion of GLT-1 specifically from neurons would affect behaviors that assessed locomotor activity, cognitive function, sensorimotor gating, social interaction, as well as amphetamine-stimulated locomotor activity. METHODS/ RESULTS: We found that the neuronal GLT-1 KO mice performed similarly to littermate controls in the behavioral tests we studied. Although performance in open field testing was normal, the acute locomotor response to amphetamine was significantly blunted in the synGLT-1 KO (40% of control). We found no change in amphetamine-stimulated extracellular dopamine in the medial shell of the nucleus accumbens, no change in electrically stimulated or amphetamine-induced dopamine release, and no change in dopamine tissue content. CONCLUSIONS: These results support the view that GLT-1 expression in neurons is required for amphetamine-induced behavioral activation, and suggest that this phenotype is not produced through a change in dopamine uptake or release. Although GLT-1 is highly expressed in neurons in the CA3 region of the hippocampus, the tests used in this study were not able to detect a behavioral phenotype referable to hippocampal dysfunction.
Authors: Michael D Saxe; Fortunato Battaglia; Jing-Wen Wang; Gael Malleret; Denis J David; James E Monckton; A Denise R Garcia; Michael V Sofroniew; Eric R Kandel; Luca Santarelli; René Hen; Michael R Drew Journal: Proc Natl Acad Sci U S A Date: 2006-11-06 Impact factor: 11.205
Authors: D N Furness; Y Dehnes; A Q Akhtar; D J Rossi; M Hamann; N J Grutle; V Gundersen; S Holmseth; K P Lehre; K Ullensvang; M Wojewodzic; Y Zhou; D Attwell; N C Danbolt Journal: Neuroscience Date: 2008-08-27 Impact factor: 3.590
Authors: Thomas S Hnasko; Nao Chuhma; Hui Zhang; Germaine Y Goh; David Sulzer; Richard D Palmiter; Stephen Rayport; Robert H Edwards Journal: Neuron Date: 2010-03-11 Impact factor: 17.173
Authors: Maddalena Mereu; Valeria Tronci; Lauren E Chun; Alexandra M Thomas; Jennifer L Green; Jonathan L Katz; Gianluigi Tanda Journal: Addict Biol Date: 2013-08-04 Impact factor: 4.280
Authors: Robert B Laprairie; Geraldine T Petr; Yan Sun; Kathryn D Fischer; Eileen M Denovan-Wright; Paul A Rosenberg Journal: Neurochem Int Date: 2018-04-27 Impact factor: 3.921
Authors: Laura F McNair; Jens V Andersen; Blanca I Aldana; Michaela C Hohnholt; Jakob D Nissen; Yan Sun; Kathryn D Fischer; Ursula Sonnewald; Nils Nyberg; Sophie C Webster; Kush Kapur; Theresa S Rimmele; Ilaria Barone; Hannah Hawks-Mayer; Jonathan O Lipton; Nathaniel W Hodgson; Takao K Hensch; Chiye J Aoki; Paul A Rosenberg; Helle S Waagepetersen Journal: J Neurosci Date: 2019-03-29 Impact factor: 6.167
Authors: Abhijeet Sharma; Syed Faraz Kazim; Chloe S Larson; Aarthi Ramakrishnan; Jason D Gray; Bruce S McEwen; Paul A Rosenberg; Li Shen; Ana C Pereira Journal: Proc Natl Acad Sci U S A Date: 2019-10-07 Impact factor: 11.205
Authors: Anca R Rǎdulescu; Gabrielle C Todd; Cassandra L Williams; Benjamin A Bennink; Alex A Lemus; Haley E Chesbro; Justin R Bourgeois; Ashley M Kopec; Damian G Zuloaga; Annalisa Scimemi Journal: PLoS Comput Biol Date: 2022-02-04 Impact factor: 4.475
Authors: J A Gomez; J M Perkins; G M Beaudoin; N B Cook; S A Quraishi; E A Szoeke; K Thangamani; C W Tschumi; M J Wanat; A M Maroof; M J Beckstead; P A Rosenberg; C A Paladini Journal: Nat Commun Date: 2019-03-29 Impact factor: 14.919
Authors: Theresa S Rimmele; Shaomin Li; Jens Velde Andersen; Emil W Westi; Alexander Rotenberg; Jianlin Wang; Blanca Irene Aldana; Dennis J Selkoe; Chiye J Aoki; Chris G Dulla; Paul Allen Rosenberg Journal: Front Cell Neurosci Date: 2021-12-29 Impact factor: 5.505